CoChat

Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson's disease

Open access

The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.

Abstract

Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. In recent years, several studies demonstrated that the gastroenteric system and intestinal microbiome influence central nervous system function. The pathological mechanisms triggered thereby change neuronal function in neurodegenerative diseases including dopaminergic neurons in Parkinson´s disease. In this study, we employed a model system for PD of cultured primary mesencephalic cells and used the pesticide rotenone to model dopaminergic cell damage. We examined neuroprotective effects of the Rho kinase inhibitor Fasudil and the short chain fatty acid (SCFA) propionic acid on primary neurons in cell morphological assays, cell survival, gene and protein expression. Fasudil application resulted in significantly enhanced neuritic outgrowth and increased cell survival of dopaminergic cells. The application of propionic acid primarily promoted cell survival of dopaminergic cells against rotenone toxicity and increased neurite outgrowth to a moderate extent. Interestingly, Fasudil augmented gene expression of synaptophysin whereas gene expression levels of tyrosine hydroxylase (TH) were substantially increased by propionic acid. Concerning protein expression propionic acid treatment increased STAT3 levels but did not lead to an increased phosphorylation indicative of pathway activation. Our findings indicate that both Fasudil and propionic acid treatment show beneficial potential in rotenone-lesioned primary mesencephalic cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules25112502

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Dose-dependent effect of different rotenone concentrations (10 nM, 20 nM, 40 nM, and 100 nM) on primary mesencephalic neurons: (a) Representative micrographs of dopaminergic midbrain neuron cultures 48 h after the treatment with rotenone labeled against tyrosine hydroxylase (TH) (green). Cell nuclei were stained with DAPI (blue); Scale bar = 50 µm. (b) Rotenone lesioning effect on the neuritic network: Mean neurite length per cell was measured in six visual fields and normalized to control (ctrl). (c) Percentage of TH-positive cells in rotenone treated cultures normalized to control. (d) Number of non-TH cells in cultures treated with different rotenone concentrations normalized to control. Bars represent mean ± SD. ns: not significant. * p < 0.05, ** p < 0.01. R10 = 10 nM, R20 = 20 nM, R40 = 40 nM and R100 = 100 nM rotenone respectively.
Figure 1 Dose-dependent effect of different rotenone concentrations (10 nM, 20 nM, 40 nM, and 100 nM) on primary mesencephalic neurons: (a) Representative micrographs of dopaminergic midbrain neuron cultures 48 h after the treatment with rotenone labeled against tyrosine hydroxylase (TH) (green). Cell nuclei were stained with DAPI (blue); Scale bar = 50 µm. (b) Rotenone lesioning effect on the neuritic network: Mean neurite length per cell was measured in six visual fields and normalized to control (ctrl). (c) Percentage of TH-positive cells in rotenone treated cultures normalized to control. (d) Number of non-TH cells in cultures treated with different rotenone concentrations normalized to control. Bars represent mean ± SD. ns: not significant. * p < 0.05, ** p < 0.01. R10 = 10 nM, R20 = 20 nM, R40 = 40 nM and R100 = 100 nM rotenone respectively.CC BY · PubMed Central
Figure 2 Effect of Rho-associated protein kinase (ROCK) inhibition and short chain fatty acid (SCFA) on rotenone treated dopaminergic neurons in six independent experiments. (a) Representative micrographs of TH+ dopaminergic neurons (green) and unspecific cell nuclei (blue) under different conditions. Cultures were treated with 20 nM rotenone (R20) and 300 µM propionic acid (P300) or 20 µM Fasudil (F20) or the combination (P+F); Scale bar = 50 µm. (b) Quantification of the neuritic outgrowth of dopaminergic neurons. Measured in six randomized visual fields per condition normalized to the control (ctrl). (c) Percentage of TH+ cells under the described conditions. (d) Number of non-TH cells normalized to the ctrl. Bars represent mean ± SD. TH = tyrosine hydroxylase. ns = not significant. * p < 0.05, ** p < 0.01.
Figure 2 Effect of Rho-associated protein kinase (ROCK) inhibition and short chain fatty acid (SCFA) on rotenone treated dopaminergic neurons in six independent experiments. (a) Representative micrographs of TH+ dopaminergic neurons (green) and unspecific cell nuclei (blue) under different conditions. Cultures were treated with 20 nM rotenone (R20) and 300 µM propionic acid (P300) or 20 µM Fasudil (F20) or the combination (P+F); Scale bar = 50 µm. (b) Quantification of the neuritic outgrowth of dopaminergic neurons. Measured in six randomized visual fields per condition normalized to the control (ctrl). (c) Percentage of TH+ cells under the described conditions. (d) Number of non-TH cells normalized to the ctrl. Bars represent mean ± SD. TH = tyrosine hydroxylase. ns = not significant. * p < 0.05, ** p < 0.01.CC BY · PubMed Central
Figure 3 Relative gene expression after treatment with propionic acid (P300) and Fasudil (F20) under 48 h rotenone (R20) exposure in six independent experiments. (a–f) Quantification of gene expression compared to housekeeping gene β-actin and normalized to the control (ctrl). Presented are (a) dopamine transporter (DAT), (b) microtubule associated protein (MAP) 2, (c) synaptophysin (SYP), (d) tyrosine hydroxylase (TH), and (e) alpha Synuclein (aSyn). Bars represent mean ± SD. ns = not significant. * p < 0.05, ** p < 0.01, *** p < 0.01.
Figure 3 Relative gene expression after treatment with propionic acid (P300) and Fasudil (F20) under 48 h rotenone (R20) exposure in six independent experiments. (a–f) Quantification of gene expression compared to housekeeping gene β-actin and normalized to the control (ctrl). Presented are (a) dopamine transporter (DAT), (b) microtubule associated protein (MAP) 2, (c) synaptophysin (SYP), (d) tyrosine hydroxylase (TH), and (e) alpha Synuclein (aSyn). Bars represent mean ± SD. ns = not significant. * p < 0.05, ** p < 0.01, *** p < 0.01.CC BY · PubMed Central
Figure 4 Activation of neuroprotective and neuroregenerative signaling pathways in midbrain dopaminergic neurons treated with or without 20 nM rotenone (R20) and 300 µM propionic acid (P300) and 20 µM Fasudil (F20). (a) Representative immunoblots showing the regulation of Akt, pAkt, signal transducer, and activator of transcription (STAT3), pSTAT3, tyrosine hydroxylase (TH), and β-actin (βAct). 10 µg protein per condition were used. (b–f) Intensity of immunoblot bands from five independent experiments for (b) Akt, (c) pAkt/Akt ratio, (d) STAT3, (e) pSTAT3/STAT3 ratio, and (f) TH compared to βAct and normalized to the control (ctrl). Bars represent mean ± SD. ** p < 0.01.
Figure 4 Activation of neuroprotective and neuroregenerative signaling pathways in midbrain dopaminergic neurons treated with or without 20 nM rotenone (R20) and 300 µM propionic acid (P300) and 20 µM Fasudil (F20). (a) Representative immunoblots showing the regulation of Akt, pAkt, signal transducer, and activator of transcription (STAT3), pSTAT3, tyrosine hydroxylase (TH), and β-actin (βAct). 10 µg protein per condition were used. (b–f) Intensity of immunoblot bands from five independent experiments for (b) Akt, (c) pAkt/Akt ratio, (d) STAT3, (e) pSTAT3/STAT3 ratio, and (f) TH compared to βAct and normalized to the control (ctrl). Bars represent mean ± SD. ** p < 0.01.CC BY · PubMed Central
Figure 5 Rotenone toxicity and neuroprotective effects of propionic acid and Fasudil on dopaminergic neurons. Rotenone inhibits the mitochondrial respiratory chain which leads to decreased adenosine triphosphate (ATP) levels, oxidative stress through reactive oxygen species (ROS) and ultimately to neurite damage and apoptosis. Gene expression levels of the dopamine transporter (DAT), microtubule associated protein 2 (MAP2), and synaptophysin (SYP) were reduced under rotenone treatment. Propionic acid increased tyrosine hydroxylase (TH) and alpha Synuclein (aSyn) gene expressions, while treatment with the Rho Kinase (ROCK) inhibitor Fasudil led to increased SYP gene expression. Both treatments had positive effects on neurite outgrowth and cell survival under rotenone toxicity.
Figure 5 Rotenone toxicity and neuroprotective effects of propionic acid and Fasudil on dopaminergic neurons. Rotenone inhibits the mitochondrial respiratory chain which leads to decreased adenosine triphosphate (ATP) levels, oxidative stress through reactive oxygen species (ROS) and ultimately to neurite damage and apoptosis. Gene expression levels of the dopamine transporter (DAT), microtubule associated protein 2 (MAP2), and synaptophysin (SYP) were reduced under rotenone treatment. Propionic acid increased tyrosine hydroxylase (TH) and alpha Synuclein (aSyn) gene expressions, while treatment with the Rho Kinase (ROCK) inhibitor Fasudil led to increased SYP gene expression. Both treatments had positive effects on neurite outgrowth and cell survival under rotenone toxicity.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 46

Metadata

Authors
Ostendorf, F., Metzdorf, J., Gold, R., Haghikia, A., & Tönges, L.
Affiliations
St. Josef-Hospital (DE)
Corresponding author
Tönges, Lars
Venue
Molecules
Publisher
MDPI AG
Published
2020-05-28
Volume
25
Issue
11
Pages
2502
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3031730348
Cited by
46
References
57
Citations by year
2025: 12 · 2024: 12 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 1
FWCI
2.38
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Dokumentenrepositorium der RUB (Ruhr University Bochum) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords
Parkinson's disease, rotenone toxicity, fasudil, propionic acid, short-chain fatty acids, Rho kinase inhibition, dopaminergic neurons, neuroprotection, neurite outgrowth, synaptophysin, tyrosine hydroxylase, STAT3, gut-brain axis, gut microbiota
MeSH terms
Animals, Cell Survival, Cells, Cultured, Female, Immunohistochemistry, Parkinson Disease, Pregnancy, Propionates, Rotenone, Tyrosine 3-Monooxygenase, Blotting, Western, Rats, Sprague-Dawley, Neuroprotective Agents, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Rats, rho-Associated Kinases, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.